Uteron Pharma : Research for woman future Uteron Pharma : Research for woman future Uteron Pharma : Research for woman future
Uteron Pharma : Research for woman future

2013/01/23 : Watson Acquires Uteron Pharma

Read more


2012/05/2 : Uteron Pharma is contemplating a public offering to finance the (...)

Read more


2012/04/24 : Professor Jean-Michel Foidart has been awarded the Bologne-Lemaire (...)

Read more



Uteron Pharma : Research for woman future

History

The roots of the Uteron Pharma’s products go back to 2002 when Belgium based Mithra Pharmaceuticals and the University of Liège decided to create a partnership to develop a hormonal intra-uterine device (IUD).

The founders of Uteron Pharma had the ambition to create an industry leader entirely dedicated to the development of women’s health products. Several new development programs were initiated with external R&D oriented organizations such as Pantarhei Bioscience, Medicines360® and EMBIC European consortium.

Initially the different product developments were structured and controlled through separate and independent legal entities. In 2010, all companies were structured and regrouped under Uteron Pharma SA. The latter was acquired by Watson Pharmaceuticals, Inc. (now Actavis plc) in January 2013.

As one of Actavis’ Centre of Excellence for women’s health products, Uteron Pharma is now focused primarily on the development of a growing portfolio of products for Actavis plc and its partners. 




© 2011 Uteron Pharma - Legal - Privacy policy Designed and Powered by Lusis Communication

Company

Background
History
Location
Contact us

Products

Levosert™
Diafert™

Production

Market

Newsroom

Uteron Pharma : Research for woman future